Machine Learning Models for Prediction of Acute Kidney Injury After Noncardiac Surgery
- Conditions
- Postoperative Acute Kidney Injury
- Registration Number
- NCT06146829
- Lead Sponsor
- Rao Sun
- Brief Summary
Acute kidney injury (AKI) is a common surgical complication characterized by a rapid decline in renal function. Patients with AKI are at an increased risk of developing chronic kidney disease and end-stage renal disease, which has been associated with an increased risk of morbidity, mortality and financial burdens. Identifying high-risk patients for postoperative AKI early can facilitate the development of preventive and therapeutic management strategies, and prediction models can be helpful in this regard.
The goal of this retrospective study is to develop prediction models for postoperative AKI in noncardiac surgery using machine learning algorithms, and to simplify the models by including only preoperative variables or only important predictors.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 88367
- Adult patients (age ≥ 18 years) who had a serum creatinine measurement within 10 days before surgery and at least one measurement within 7 days after surgery.
- Eligible surgeries encompassed general, thoracic, orthopedic, obstetric, gynecology, and neurosurgery procedures lasting longer than 1 hour
- Patients with concurrent cardiac, vascular, urological, or transplant surgeries.
- Patients with an American Society of Anesthesiologists (ASA) physical status V.
- Patients with end-stage renal disease (i.e., a glomerular filtration rate [eGFR] of 15 mL/min/1.73 m² or receiving hemodialysis).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative acute kidney injury Within 7 days after surgery In accordance with the KDIGO creatinine criteria: a serum creatinine increases of 26.5 mmol/L within 48 hours or 1.5 times baseline within 7 days after surgery.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Rao Sun
🇨🇳Wuhan, Hubei, China